Maze Therapeutics (MAZE) Stock Chart & Stock Price History $10.28 +0.11 (+1.08%) As of 05/23/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Maze Therapeutics Stock Price Performance The Maze Therapeutics (MAZE) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 25.21%, reflecting recent market activity. As of the latest close, Maze Therapeutics traded at $10.28 with a market cap of $450.23 million and volume of 39,436 shares. Receive MAZE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.68%1 Month Performance+25.21%3 Month Performance-2.74% MAZE Stock Chart for Sunday, May, 25, 2025 MAZE Chart by TradingView Maze Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/23/2025$10.17$10.28+1.08%$10.40$9.7539,436 shs$450.23 million05/22/2025$10.52$10.17-3.33%$10.63$9.9448,425 shs$445.42 million05/21/2025$10.11$10.52+4.06%$10.63$9.8798,075 shs$460.74 million05/20/2025$9.70$10.11+4.23%$10.33$9.4177,225 shs$442.79 million05/19/2025$9.25$9.70+4.86%$9.88$9.1688,405 shs$424.82 million05/16/2025$9.25$9.25$9.35$8.8184,952 shs$405.11 million05/15/2025$9.06$9.25+2.10%$9.33$8.25100,486 shs$405.11 million05/14/2025$9.86$9.06-8.11%$10.08$8.75105,888 shs$396.79 million05/13/2025$10.13$9.86-2.67%$10.39$9.5574,822 shs$431.83 million05/12/2025$9.73$10.13+4.11%$10.26$9.60113,779 shs$443.65 million Get the Latest News and Ratings for MAZE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2025$10.02$9.73-2.89%$10.52$9.5766,086 shs$426.14 million05/08/2025$9.52$10.02+5.25%$10.38$9.2581,910 shs$438.84 million05/07/2025$9.11$9.52+4.50%$9.70$8.77210,120 shs$416.94 million05/06/2025$10.42$9.11-12.57%$10.63$8.94131,647 shs$398.98 million05/05/2025$10.85$10.42-3.96%$10.74$10.1076,213 shs$456.35 million05/02/2025$10.59$10.85+2.46%$11.98$10.64301,086 shs$475.19 million05/01/2025$9.25$10.59+14.49%$10.81$9.11182,747 shs$463.80 million04/30/2025$8.79$9.25+5.23%$9.32$8.56799,429 shs$405.11 million04/29/2025$8.38$8.79+4.89%$8.97$7.99329,824 shs$384.97 million04/28/2025$8.21$8.38+2.07%$8.60$7.79213,196 shs$367.01 million04/25/2025$7.70$8.21+6.62%$8.34$7.16307,364 shs$359.57 million04/24/2025$9.55$7.70-19.37%$9.76$7.50225,305 shs$337.23 million Related Companies Indivior Stock Chart IDEAYA Biosciences Stock Chart Edgewise Therapeutics Stock Chart Immunocore Stock Chart Mesoblast Stock Chart Travere Therapeutics Stock Chart Structure Therapeutics Stock Chart Evotec Stock Chart Janux Therapeutics Stock Chart Adaptive Biotechnologies Stock Chart Receive MAZE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MAZE) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maze Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maze Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MAZE Stock Free MAZE Stock Alerts